5 min

Dose-Finding Trials: Optimizing Phase 2 Data in the Drug Development Process with Dr Kert Viele JAMAevidence Users' Guides to the Medical Literature

    • Medicine

Ed Livingston, MD, FACS, AGAF, discusses Dose-Finding Trials: Optimizing Phase 2 Data in the Drug Development Process with Kert Viele, PhD

  • American Medical Association 2021

Ed Livingston, MD, FACS, AGAF, discusses Dose-Finding Trials: Optimizing Phase 2 Data in the Drug Development Process with Kert Viele, PhD

5 min

  • American Medical Association 2021

More by JAMA Network

JAMA Clinical Reviews
JAMA Clinical Reviews
JAMA Network
JAMA Medical News
JAMA Medical News
JAMA Network
JAMA Psychiatry Author Interviews
JAMA Psychiatry Author Interviews
JAMA Network
JAMAevidence JAMA Guide to Statistics and Methods
JAMAevidence JAMA Guide to Statistics and Methods
JAMA Network
JAMAevidence The Rational Clinical Examination
JAMAevidence The Rational Clinical Examination
JAMA Network
JAMA Author Interviews
JAMA Author Interviews
JAMA Network